Tarenflurbil and Alzheimer's Disease; Mag Sulfate and Cerebral Palsy; PRoFESS and Recurrent Stroke; PCB's and Cognitive Decline.
- Submission
Tarenflurbil and Alzheimer's Disease; Mag Sulfate and Cerebral Palsy; PRoFESS and Recurrent Stroke; PCB's and Cognitive Decline.
Phase III data for Tarenflurbil for the treatment of Alzheimer's disease has been reported. A new study examines the efficacy of magnesium sulfate to prevent Cerebral Palsy in pre-term infants. PRoFESS data are analyzed for the prevention of secondary stroke. PCB exposure is associated with cognitivie difficulties.
Submission | September 5, 2008
